EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of Lung Adenocarcinoma Growth by using Oridonin

Zhongrui Jiang

MedScien · 2023

DOI: 10.61173/0f01c260 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MedScien, 2023. Verfasst von Zhongrui Jiang. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The abnormal activity of the Notch signal pathway is a common manifestation of many cancerous cells. Therefore,blocking the notch pathway of cancer cells positively affects cancer treatment. Because oridonin directly acts on thetarget notch receptor 1-4 cancer cells, inhibiting the Notch signaling pathway can inhibit the growth of cancer cells.

Zitieren

APA

Jiang, Z. (2023). Inhibition of Lung Adenocarcinoma Growth by using Oridonin. MedScien. https://doi.org/10.61173/0f01c260

Vancouver

Jiang Z. Inhibition of Lung Adenocarcinoma Growth by using Oridonin. MedScien. 2023. doi:10.61173/0f01c260

BibTeX
@article{Jiang2023,
  author = {Jiang, Zhongrui},
  title = {Inhibition of Lung Adenocarcinoma Growth by using Oridonin},
  journal = {MedScien},
  year = {2023},
  doi = {10.61173/0f01c260}
}
Kostenlos starten →